Nautilus Biotechnology, Inc.
NAUT- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001808805
No open-market purchases or sales by Nautilus Biotechnology, Inc. insiders were filed in the last 90 days; 93 institutions reported holding it in 13F filings for Q2 2026, worth $93.7M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Nautilus Biotechnology, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 76 | 73 | −3 |
| Shares | 63.4M | 63.2M | −184.9K (−0.3%) |
| Value | $189.6M | $185.9M | −$3.72M (−2.0%) |
New holders (5)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wexford Capital LP | 159,101 | $467.8K | 0.10% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 20,983 | $61.7K | 0.00% |
| XTX Topco Ltd | 11,594 | $34.1K | 0.00% |
| CIBC Private Wealth Group, LLC | 200 | $600 | 0.00% |
| CWM, LLC | 3 | $0 | 0.00% |
Sold out (8)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| MetLife Investment Management | 28,043 | $83.8K |
| Virtu Financial LLC | 26,337 | $79.0K |
| Susquehanna International Group, LLP | 21,710 | $64.9K |
| State Board of Administration of Florida Retirement System | 14,480 | $43.3K |
| Axxcess Wealth Management, LLC | 10,000 | $29.9K |
| Federated Hermes, Inc. | 9,500 | $28.4K |
| Metropolitan Life Insurance Co | 803 | $2.40K |
| The PNC Financial Services Group, Inc. | 11 | $33 |